The pharmwatch programme: Challenges to engaging the community pharmacists in Jamaica

Pharmacy Practice

Volumn 6, Issue 4, 2008, Pages 187-190

  Gossell Williams, Maxine ^a   Adebayo, Sarafadeen A ^b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY OF TECHNOLOGY   (Jamaica)

Author keywords

Adverse drug reaction reporting systems; Jamaica; Pharmacists

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; AWARENESS; COMMUNITY; DRUG INDUSTRY; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; JAMAICA; PHARMACIST ATTITUDE; QUESTIONNAIRE; RESPONSIBILITY;

EID: 63449115162     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552008000400003     Document Type: Article

References (21)

1. Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand:implications for pharmacists. Ther Clin Risk Manag. 2005;1(3):181-188.
2. World Health Organization. Safety of Medicines. Guidelines for setting up and running a pharmacovigilance centre. Geneva:WHO;2000.
3. World Health Organization. Safety of Medicines. A guide to detecting and reporting adverse drug reactions. Why health professionals need to take action. Geneva:WHO;2002.
4. Edwards IR, Aronson JK. Adverse drug reaction: Definitions, diagnosis and management. Lancet. 2000;356:1255-1259.
5. Lasser KE, Allen PD, Woolhandler SJ Himmelstein DU, Wolfe SM. Timing of new blackbox warnings and withdrawals for prescription medication. JAMA 2002;287:2215-2220.
6. Wysowski D, Swartz L. Adverse Drug Surveillance and Drug Withdrawals in the United States, 1969-2000. Arch Intern Med. 2005;165:1363-1369.
7. Rainsford KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem 2007;42:3-27.
8. Sanger GJ, Alpers DH. Development of drugs for gastrointestinal motor disorders: translating science to clinical need. Neurogastroenterol Motil. 2008;20(3):177-184.
9. van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13:457-464.
10. Terceros Y, Chahine-Chaktoura C, Malinowski JE, Rickley WF. Impact of a pharmacy resident on hospital length of stay and drug-related costs. Ann Pharmacother. 2007;41(5):742-748.
11. Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm. 2007;64(8):842-849.
12. Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275-280.
13. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001;137(6):765-770.
14. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev. 2001;53(3):357-379.
15. Gossell-Williams M. Generic Substitutions: A 2005 survey of the acceptance and perceptions of physicians in Jamaica. West Indian Med J. 2007;56(5):458-463.
16. Gossell-Williams M, Harriott K. Generic substitution in Jamaica:challenges to improving effectiveness. WHO Drug Information. 2007;21(4):294-299.
17. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51(1):81-86
18. Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernandez-Diaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073-1082
19. Bracchi R, Houghton J, Woods F, Thomas S Small SA, Routledge P. A distant-learning programme in pharmacovigilance linked to educational credits is associated with imporved reporting of suspected adverse drug reactions via the UK yellow card system. Br J Clin Pharmacol. 2005;60(2):221-223.
20. Sweis D, Wong ICK. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000;23:165-172.
21. Herdeiro MT, Polonia J, Gestal-Otero JJ, Figueiras A. Improving the reporting of adverse drug reactions: a clusterrandomized trial among pharmacists in Portugal. Drug Saf. 2008; 31(4):335-344.